Home

főnök instruct Meggyőzés cap db m Végzetes ugrás réteg

My FibroScan Experience and Test Results
My FibroScan Experience and Test Results

Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver  disease in patients undergoing bariatric surgery | Scientific Reports
Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery | Scientific Reports

NON-OBESE NAFLD IS ASSOCIATED WITH HIGHER SCD14 CONCENTRATIONS IN ADULTS  WITH HIV
NON-OBESE NAFLD IS ASSOCIATED WITH HIGHER SCD14 CONCENTRATIONS IN ADULTS WITH HIV

Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods:  Possible Use in Fatty Liver Disease Area
Diagnostics | Free Full-Text | Ultrasound-Based Diagnostic Methods: Possible Use in Fatty Liver Disease Area

Controlled attenuation parameter for the assessment of liver steatosis in  comparison with liver histology: a single-centre real life experience |  Swiss Medical Weekly
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience | Swiss Medical Weekly

Using controlled attenuation parameter combined with ultrasound to survey  non-alcoholic fatty liver disease in hemodialysis patients: A prospective  cohort study | PLOS ONE
Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study | PLOS ONE

Parameters associated with NAFLD (CAP ≥ 248 dB/m). | Download Scientific  Diagram
Parameters associated with NAFLD (CAP ≥ 248 dB/m). | Download Scientific Diagram

Frontiers | Validation of Controlled Attenuation Parameter Measured by  FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic  Derangement
Frontiers | Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement

Fibroscan™ (Sound Based Elastography) | Gastro Health - Framingham
Fibroscan™ (Sound Based Elastography) | Gastro Health - Framingham

EPOS™ - C-01454
EPOS™ - C-01454

COMPARISON OF THE BASELINE CHARACTERISTICS OF PATIENTS WITH CAP < 220... |  Download Table
COMPARISON OF THE BASELINE CHARACTERISTICS OF PATIENTS WITH CAP < 220... | Download Table

Quick assessment with controlled attenuation parameter for hepatic  steatosis in children based on MRI-PDFF as the gold standard | BMC  Pediatrics | Full Text
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard | BMC Pediatrics | Full Text

Factors associated with CAP ! 238 dB/m vs. CAP | Download Table
Factors associated with CAP ! 238 dB/m vs. CAP | Download Table

SMART SCAN , Fibroscan, Liver elastography and CAP scan - Gastrointestinal  and Liver Clinic
SMART SCAN , Fibroscan, Liver elastography and CAP scan - Gastrointestinal and Liver Clinic

Prevalence of fatty liver and advanced fibrosis by ultrasonography and  FibroScan in a general population random sample - Nagaoki - 2022 -  Hepatology Research - Wiley Online Library
Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample - Nagaoki - 2022 - Hepatology Research - Wiley Online Library

Hepatic steatosis on FibroScan with controlled attenuation parameter... |  Download Scientific Diagram
Hepatic steatosis on FibroScan with controlled attenuation parameter... | Download Scientific Diagram

Fibroscan - Dr Douglas Samuel
Fibroscan - Dr Douglas Samuel

CPDH | Pediatric Endocrinology
CPDH | Pediatric Endocrinology

Performance of Controlled Attenuation Parameter in Patients with Advanced  Chronic Liver Disease and Portal Hypertension | Digestive Diseases and  Sciences
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension | Digestive Diseases and Sciences

Controlled attenuation parameter for the assessment of liver steatosis in  comparison with liver histology: a single-centre real life experience
Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience

What Is a Fibroscan?
What Is a Fibroscan?

Fibroscan - Dr Douglas Samuel
Fibroscan - Dr Douglas Samuel

Improvement in liver stiffness measurement for diagnosis of liver fibrosis  in patients with concurrent chronic hepatitis B and nonalcoholic fatty  liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu
Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease - Nan Xu, Qinxiu Xie, Jiang Li, Yufeng Gao, Xu

Factors associated with CAP ! 238 dB/m vs. CAP | Download Table
Factors associated with CAP ! 238 dB/m vs. CAP | Download Table